Pharmaceutical News and Articles

Urine Albumin-to-Creatinine Ratio Indicates Risk in Rheumatoid Arthritis

For patients with rheumatoid arthritis (RA), urine albumin-to-creatinine ratio (ACR) is an independent risk factor indicating prognosis, according to a study pu

Increasing Amount of Breast Cancer-Specific Death Due to Stage 1, 2 Disease

Patients with stage I II breast cancers have excellent prognosis, but account for more than 60 percent of breast cancer-specific death (BCSD) because of their l

About 6% of U.S. Adults Have ADHD, Drug Shortages Are Affecting Treatment

More than 15.5 million U.S. adults have been diagnosed with ADHD, and nearly three-quarters of those taking medication to treat it say drug shortages are hamper

FDA Approves Itovebi (inavolisib) for the Treatment of Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation

Loneliness Raises Odds for Dementia by 31%

i.e. how long we live, noted S illeabh in, who directs the Personality, Individual Differences and Biobehavioral Health Laboratory at the Irish university. Lone

Six-Week Abortion Bans: More Than a Third of Women Don't Know They Are Pregnant by 6 Weeks

have to arrange out-of-state travel to obtain an abortion, researchers said. That can mean hundreds of miles of travel across multiple state lines. Six-week abo

A Robot Finger Might Someday Take Your Pulse, Check for Tumors

A newly developed soft robotic finger with a sophisticated sense of touch could one day help your doctor perform routine office examinations, a new study sugges

Think Your Opinion Must Be Right? Science Reveals Why You May Be Wrong

Attention all know-it-alls. Folks who are sure they re right often believe they ve got enough information to make up their minds, even if in reality they only h

U.S. Scrambles to Find Hospital IV Fluids After Helene Damages NC Plant

to restart operations and help ensure patients and providers have the products they need, Jos Almeida, the chief executive at Baxter, said in a statement Wednes

Positive Top-line Results from Phase 3 Study of Effexor in Japanese Adults with Generalized Anxiety Disorder

PITTSBURGH and TOKYO, Oct. 9, 2024. Viatris Inc., a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japa